These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35901206)

  • 21. Primary Nucleation Kinetics of Short Fibril-Forming Amyloidogenic Peptides.
    Luiken JA; Bolhuis PG
    J Phys Chem B; 2015 Oct; 119(39):12568-79. PubMed ID: 26340561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
    Benseny-Cases N; Klementieva O; Cladera J
    Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational studies of protein aggregation mediated by amyloid: Fibril elongation and secondary nucleation.
    Cao Y; Tang X; Yuan M; Han W
    Prog Mol Biol Transl Sci; 2020; 170():461-504. PubMed ID: 32145951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into amyloid-like aggregation of H2 region of the C-terminal domain of nucleophosmin.
    Russo A; Diaferia C; La Manna S; Giannini C; Sibillano T; Accardo A; Morelli G; Novellino E; Marasco D
    Biochim Biophys Acta Proteins Proteom; 2017 Feb; 1865(2):176-185. PubMed ID: 27865970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of oligomers of heterogeneous size as precursors of amyloid fibril nucleation of an SH3 domain: an experimental kinetics study.
    Ruzafa D; Morel B; Varela L; Azuaga AI; Conejero-Lara F
    PLoS One; 2012; 7(11):e49690. PubMed ID: 23209591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary nucleation in amyloid formation.
    Törnquist M; Michaels TCT; Sanagavarapu K; Yang X; Meisl G; Cohen SIA; Knowles TPJ; Linse S
    Chem Commun (Camb); 2018 Aug; 54(63):8667-8684. PubMed ID: 29978862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of primary and secondary nucleation alongwith disruption of amyloid fibrils and alleviation of associated cytotoxicity: A biophysical insight of a novel property of Chlorpropamide (an anti-diabetic drug).
    Majid N; Siddiqi MK; Hassan MN; Malik S; Khan S; Khan RH
    Biomater Adv; 2023 Aug; 151():213450. PubMed ID: 37148596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation.
    Ranjan P; Ghosh D; Yarramala DS; Das S; Maji SK; Kumar A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):365-374. PubMed ID: 27916677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
    Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
    Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides.
    Meisl G; Yang X; Hellstrand E; Frohm B; Kirkegaard JB; Cohen SI; Dobson CM; Linse S; Knowles TP
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9384-9. PubMed ID: 24938782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensing and modulation of amyloid fibrils by photo-switchable organic dots.
    Uddin A; Roy B; Jose GP; Hossain SS; Hazra P
    Nanoscale; 2020 Aug; 12(32):16805-16818. PubMed ID: 32761038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential for amyloid surface inhibitor: only amyloid-β oligomers formed by secondary nucleation disrupt lipid membrane integrity.
    Tian Y; Liu J; Yang F; Lian C; Zhang H; Viles JH; Li Z
    FEBS J; 2022 Nov; 289(21):6767-6781. PubMed ID: 35670622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Silico Analysis of Nanoplastics' and β-amyloid Fibrils' Interactions.
    Gabbrielli S; Colnaghi L; Mazzuoli-Weber G; Redaelli ACL; Gautieri A
    Molecules; 2023 Jan; 28(1):. PubMed ID: 36615582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-Seeding with Homologous Sequences Alters Amyloid Aggregation Kinetics and Fibril Structure.
    Nag N; Tripathi T
    ACS Chem Neurosci; 2022 Mar; 13(5):537-539. PubMed ID: 35152697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism.
    Chaudhuri P; Prajapati KP; Anand BG; Dubey K; Kar K
    Ageing Res Rev; 2019 Dec; 56():100937. PubMed ID: 31430565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling Amyloid Aggregation Kinetics: A Case Study with Sup35NM.
    Sharma A; McDonald MA; Rose HB; Chernoff YO; Behrens SH; Bommarius AS
    J Phys Chem B; 2021 May; 125(19):4955-4963. PubMed ID: 33961433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early mechanisms of amyloid fibril nucleation in model and disease-related proteins.
    Morel B; Conejero-Lara F
    Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140264. PubMed ID: 31437584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic Origin of the Combined Effect of Surfaces and Mechanical Agitation on Amyloid Formation.
    Grigolato F; Colombo C; Ferrari R; Rezabkova L; Arosio P
    ACS Nano; 2017 Nov; 11(11):11358-11367. PubMed ID: 29045787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phloroglucinol, a clinical-used antispasmodic, inhibits amyloid aggregation and degrades the pre-formed amyloid proteins.
    Xie Y; Lu J; Yang T; Chen C; Bao Y; Jiang L; Wei H; Wu X; Zhao L; He S; Lin D; Liu F; Liu H; Yan X; Cui W
    Int J Biol Macromol; 2022 Jul; 213():675-689. PubMed ID: 35667457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.